NCT07635576
Effect of Gastric Electrical Stimulation on Serum Insulin Levels
Recruiting
NAAges 18–70InterventionalHealth servicesIndiana UniversityInvestigator-initiated
~32 participants
Updated 2026-06-09 on ClinicalTrials.gov
What's tested:Gastric Electrical Stimulator
At a glance
Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Definition of Effect
Measured over Up to four hours depending on the subject's preference/tolerability.
Conditions
Where it's being run
2 sites across 1 statesIndiana2
Study leadership
- Thomas V Nowak, MD · PRINCIPAL_INVESTIGATOR · IU School of Medicine/IU Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
• At least 18 years of age.
Documented diagnosis of gastroparesis
Not taking diabetic prescribed exogenous insulin.
Patient has a GES device that has been implanted for at least 3 months.
Willing to give up to 8 blood samples.
Willing to lie in a bed for up to 5.5 hours.
Exclusion
• Pregnancy
History of allergic reaction to EKG lead placement adhesives.
Unable to give informed consent.
Unwilling to give up to 8 5 ml blood samples.
Unwilling to lie in a bed for up to 5.5 hours.
What this trial measures
- Definition of EffectUp to four hours depending on the subject's preference/tolerability.
To define the effect of prolonged four-hour withdrawal of gastric electrical stimulation on serum insulin and C-peptide levels in human subjects. Insulin and C-peptide are co-primary end points.